Showing 1-10 of 1732 results for "".
- https://practicalneurology.com/about-practical-neurology/Launched in 2002, Practical Neurology® is uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news to facilitate practical application of recent advances in neurology and improve clinical practice for all neuro…
- OCT 2017 ISSUE - Archiveshttps://practicalneurology.com/archives/2017-oct/
- NOV-DEC 2017 ISSUE - Archiveshttps://practicalneurology.com/archives/2017-nov-dec/
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.- Leaving AEDs Behind: When to Withdraw Therapy in Seizure-free Patientshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1008_04-pdf/30980/Managing Antiepileptic Drug (AED) Therapy in Seizure-Free Patients: Key ConsiderationsAchieving complete seizure control is the primary objective in epilepsy management, significantly improving patient quality of life. In specific epilepsy syndromes, such as benign rolandic epilepsy (childhood epile
Multiple Sclerosis--Is it One Disease or Many Diseases?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-is-it-one-disease-or-many-diseases/30103/Dr. Stephen Krieger will share his view that MS is one disease state while Dr. Bianca Weinstock-Guttman challenges that view, arguing that MS is many disease states.Why Are Clinical Trials for People With Alzheimer's Disease So Challenging?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/why-are-clinical-trials-for-people-with-alzheimers-disease-so-challenging/30204/Answers from attendees at the American Alzheimer's International Conference in Chicago, Illinois, July 22-26, 2018.- When Life Is "Fragrance-Free" — Taste & Smell Disorders In Clinical Neurologyhttps://practicalneurology.com/columns/practice-management/when-life-is-fragrance-free-taste-smell-disorders-in-clinical-neurology/31067/Taste and Smell Disorders: Emerging Concerns in Clinical NeurologyTaste and smell disorders are increasingly recognized within clinical neurology, expanding beyond their traditional focus in otorhino-laryngology. Dr. Ronald Devere underscores the rising prevalence of these sensory impairments in var
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0307-epilepsy-pdf/31201/Epilepsy and migraine are frequently comorbid neurological disorders, with individuals diagnosed with epilepsy experiencing a higher prevalence of migraine than the general population. Approximately 24% of epilepsy patients and 26% of their relatives report migraines, compared to a 15% prevalence in
Medical Marijuana: One Pathway Clears, Other Roadblocks Re-Enforced
https://practicalneurology.com/columns/practice-management/neurology-in-the-media/30436/Where Neurology and #Culture Intersect
- Prev
- Next